
Corrective actions, preventive actions, and deviation tracking
CAPA (Corrective and Preventive Action) and deviation management systems are essential for pharmaceutical quality, enabling companies to track quality events, investigate deviations, identify root causes, implement corrective actions, and prevent recurrence. These integrated platforms manage the complete lifecycle from deviation reporting through CAPA closure, ensuring FDA compliance through structured investigation workflows, effectiveness checks, and complete documentation.
CAPA and deviation management software provides structured workflows for investigating quality issues including manufacturing deviations, out-of-specification (OOS) results, out-of-trend (OOT) results, complaints, audit findings, and nonconformances. It enforces investigation timelines, captures impact assessments, guides root cause analysis methodologies (5 Whys, Fishbone, FMEA), tracks corrective and preventive actions, manages effectiveness checks, and maintains FDA-inspectable records throughout the entire quality event lifecycle.
CAPA and deviation management systems must comply with FDA 21 CFR Part 11 and 21 CFR 211.192 (investigation of deviations). Systems must demonstrate timely investigation of quality events, appropriate root cause analysis, effective corrective actions, and verification of effectiveness. For deviations, systems must support impact assessment, batch disposition decisions, and OOS investigations per FDA guidance. Complete audit trails and electronic signatures are required for regulatory inspections.
Browse our directory of pharmaceutical capa & deviation management vendors. Compare features, pricing, and real user reviews to make an informed decision.